FK506
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for FK506, covering 2010-05-27 to 2014-08-25. Get the full timeline:
Most recent: Clinical Trial Update: FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients [Phase 3]